ATE237594T1 - Sulfonylpyrimidine derivate mit antitumor wirkung - Google Patents
Sulfonylpyrimidine derivate mit antitumor wirkungInfo
- Publication number
- ATE237594T1 ATE237594T1 AT98108370T AT98108370T ATE237594T1 AT E237594 T1 ATE237594 T1 AT E237594T1 AT 98108370 T AT98108370 T AT 98108370T AT 98108370 T AT98108370 T AT 98108370T AT E237594 T1 ATE237594 T1 AT E237594T1
- Authority
- AT
- Austria
- Prior art keywords
- derivatives
- sulfonylpyrimidine
- tumor effect
- disulfonyl
- cytostatic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HR970239A HRP970239B1 (en) | 1997-05-09 | 1997-05-09 | Process for the preparation of sulfonyl-pyrimidine derivatives with antitumor activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE237594T1 true ATE237594T1 (de) | 2003-05-15 |
Family
ID=10946575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98108370T ATE237594T1 (de) | 1997-05-09 | 1998-05-07 | Sulfonylpyrimidine derivate mit antitumor wirkung |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0877022B1 (de) |
| AT (1) | ATE237594T1 (de) |
| CA (1) | CA2237267A1 (de) |
| CZ (1) | CZ142498A3 (de) |
| DE (1) | DE69813362T2 (de) |
| HR (1) | HRP970239B1 (de) |
| PL (1) | PL326236A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0949250B1 (de) * | 1998-03-30 | 2006-05-03 | F. Hoffmann-La Roche Ag | Verfahren zu Fabrikation von Alpha 1l-Adrenorezeptor Antagonisten |
| JP5749017B2 (ja) | 2008-01-22 | 2015-07-15 | ダウ アグロサイエンシィズ エルエルシー | ５−フルオロピリミジン誘導体 |
| UA112284C2 (uk) | 2009-08-07 | 2016-08-25 | ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі | Похідні 5-фторпіримідинону |
| RS53395B (en) * | 2009-08-07 | 2014-10-31 | Dow Agrosciences Llc | DERIVATIVES N1-SULFONIL-5-FLUORPIRIMIDINONA |
| UA106889C2 (uk) | 2009-08-07 | 2014-10-27 | ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі | Похідні n1-ацил-5-фторпіримідинону |
| UA107671C2 (en) | 2009-08-07 | 2015-02-10 | Dow Agrosciences Llc | N1-substityted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives |
| UA109780C2 (uk) | 2010-01-07 | 2015-10-12 | ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі | ТІАЗОЛО[5,4-d]ПІРИМІДИНИ І ЇХ ЗАСТОСУВАННЯ ЯК АГРОХІМІЧНИХ ЗАСОБІВ |
| MX2012012530A (es) * | 2010-04-26 | 2012-12-17 | Dow Agrosciences Llc | Derivados de n1-sulfonil-5-fluorpirimidinona. |
| WO2013025795A1 (en) | 2011-08-17 | 2013-02-21 | Dow Agrosciences Llc | 5-fluoro-4-imino-3-(substituted)-3,4-dihydropyrimidin-2-(1h)-one derivatives |
| KR20150103096A (ko) | 2012-12-28 | 2015-09-09 | 다우 아그로사이언시즈 엘엘씨 | N-(치환된)-5-플루오로-4-이미노-3-메틸-2-옥소-3,4-디히드로피리미딘-1(2h)-카르복실레이트 유도체 |
| US9271497B2 (en) | 2012-12-28 | 2016-03-01 | Dow Agrosciences Llc | 1-(substituted-benzoyl)-5-fluoro-4-imino-3-methyl-3,4-dihydropyrimidin-2(1H)-one derivatives |
| CN104884062B (zh) | 2012-12-28 | 2018-11-06 | 阿达玛马克西姆股份有限公司 | N-(取代的)-5-氟-4-亚氨基-3-甲基-2-氧代-3,4-二氢嘧啶-1(2h)-甲酰胺衍生物 |
| RU2644014C2 (ru) | 2012-12-31 | 2018-02-07 | Адама Мактешим Лтд. | Производные 3-алкил-5-фтор-4-замещенного-имино-3,4-дигидропиримидин-2(н)-она в качестве фунгицидов |
| EA201691353A1 (ru) * | 2013-12-31 | 2016-12-30 | Адама Мактешим Лтд. | 5-фтор-4-имино-3-(алкил/замещенный алкил)-1-(арилсульфонил)-3,4-дигидропиримидин-2(1h)-он и способы их получения |
| EP3096619A4 (de) | 2013-12-31 | 2017-09-06 | Adama Makhteshim Ltd | Synergistische fungizide gemische zur pilzbekämpfung bei getreidepflanzen |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5324951B2 (de) * | 1973-11-28 | 1978-07-24 | ||
| JPS51105080A (en) * | 1975-03-07 | 1976-09-17 | Mitsui Seiyaku Kogyo Kk | 55 furuororashirujudotainoseizohoho |
| GB1570555A (en) * | 1977-04-05 | 1980-07-02 | Taiho Pharmaceutical Co Ltd | Anti-cancer composition |
| JPS5587777A (en) * | 1978-12-27 | 1980-07-02 | Ono Pharmaceut Co Ltd | Pyrimidine derivative, its preparation and antitumorigenic agent |
| JPS6293281A (ja) * | 1985-10-17 | 1987-04-28 | Kyowa Hakko Kogyo Co Ltd | 抗腫瘍剤 |
-
1997
- 1997-05-09 HR HR970239A patent/HRP970239B1/xx not_active IP Right Cessation
-
1998
- 1998-05-07 CZ CZ981424A patent/CZ142498A3/cs unknown
- 1998-05-07 DE DE69813362T patent/DE69813362T2/de not_active Expired - Lifetime
- 1998-05-07 EP EP98108370A patent/EP0877022B1/de not_active Expired - Lifetime
- 1998-05-07 AT AT98108370T patent/ATE237594T1/de not_active IP Right Cessation
- 1998-05-08 CA CA002237267A patent/CA2237267A1/en not_active Abandoned
- 1998-05-11 PL PL98326236A patent/PL326236A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69813362D1 (de) | 2003-05-22 |
| EP0877022B1 (de) | 2003-04-16 |
| CZ142498A3 (cs) | 1999-08-11 |
| EP0877022A1 (de) | 1998-11-11 |
| PL326236A1 (en) | 1998-11-23 |
| HRP970239B1 (en) | 2004-04-30 |
| CA2237267A1 (en) | 1998-11-09 |
| HRP970239A2 (en) | 1999-02-28 |
| DE69813362T2 (de) | 2004-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE237594T1 (de) | Sulfonylpyrimidine derivate mit antitumor wirkung | |
| FI932032A (fi) | Kinazolinderivat foer oekande av antitumoeraktivitet | |
| TR199800012T1 (xx) | Piroloprimidinler ve preparasyon i�in tatbikler. | |
| DE9290018U1 (de) | 2,4-Diaminochinazolin-Derivate zur Verbesserung der Antitumor-Aktivität | |
| DE69710490D1 (de) | Triazolo(4,5-d)pyrimidinyl-derivate und ihre verwendung als medikamente | |
| TR199801755T2 (xx) | Pirimido(5,4-D)pirimidinler, bu bile�ikleri i�eren farmas�tik maddeler. | |
| DE69426904T2 (de) | Phosphonat-Nukleotid Ester-Derivate | |
| AU7533091A (en) | N-(3-fluoro-2-phosphonylmethoxypropyl) derivatives of purine and pyrimidine heterocyclic bases, their preparation and use | |
| IT1297080B1 (it) | Composizione per il trattamento di ustioni, eritemi solari, abrasioni, piaghe e irritazioni cutanee | |
| ATE119157T1 (de) | Pyrimidinderivate zur erhöhung der antitumoraktivität. | |
| AU586043B2 (en) | Imidazo``1,5-a``quinazoline derivatives, their preparation and use. | |
| ATE149498T1 (de) | Radicicol-derivate, ihre herstellung und ihre antitumorwirkung | |
| DE69812177D1 (de) | 3'-epi k-252a derivate | |
| DE3767175D1 (de) | Therapeutische zusammenstellungen auf basis von 3-alkoxyflavonen und derivate von 3-alkoxyflavonen. | |
| DK478485D0 (da) | 4-oxo-pyrido(2,3-d)pyrimidin-derivater, deres fremstilling og anvendelse | |
| SE8902340D0 (sv) | Mitomycin phosphate derivatives | |
| DE60003560D1 (de) | 1,2-dihydro-1-oxo-pyrazino[1,2-]indolederivate | |
| DK522187D0 (da) | Imidozothienopyrimidiner, deres fremstilling og anvendelse | |
| GR920100523A (el) | Ενώσεις. | |
| ES2051722T3 (es) | Procedimiento para estabilizar derivados de procaterol. | |
| RU93034452A (ru) | Производные хиназолинов для усиления противоопухолевой активности, способ их получения, способ лечения и фармацевтическая композиция |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |